Validating Ebola test with stored blood samples
Part of Infections clinical trials.
This study checks how well a new Ebola test works using blood samples stored from past patients. It may help improve future diagnosis and treatment of Ebola.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a stored blood sample from when you had Ebola or were tested for it.
- Your sample must be labeled as either Ebola-positive or Ebola-negative.
- The sample must be stored in a biobank and available for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks a new, faster test for Ebola and Lassa viruses using stored blood samples from past infections. It compares the new test's results with the original diagnosis to see if the quick test is accurate.
This trial tests an experimental treatment to prevent Ebola infection in people who have had close contact with someone infected with Ebola within the last 5 days. If you've been in a high-risk situation, joining this trial could help protect you and others.
This trial collects and studies blood samples from people with blood disorders. It may help researchers better understand blood conditions using lab testing rather than a new medication.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This Phase 2 study compares Ebola vaccine immune responses when one Ebola treatment (Inmazeb) is given, then a vaccine (Ervebo) is given later. The goal is to see how the delay in timing changes your body’s immune response.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
Hear when a new Ebola Hemorrhagic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.